A mechanism for exon skipping caused by nonsense or missense mutations in BRCA1 and other genes

被引:0
|
作者
Hong-Xiang Liu
Luca Cartegni
Michael Q. Zhang
Adrian R. Krainer
机构
[1] Cold Spring Harbor Laboratory,
[2] Xencor Inc.,undefined
来源
Nature Genetics | 2001年 / 27卷
关键词
D O I
暂无
中图分类号
学科分类号
摘要
Point mutations can generate defective and sometimes harmful proteins. The nonsense-mediated mRNA decay (NMD) pathway minimizes the potential damage caused by nonsense mutations1,2,3,4. In-frame nonsense codons located at a minimum distance upstream of the last exon-exon junction are recognized as premature termination codons (PTCs), targeting the mRNA for degradation. Some nonsense mutations cause skipping of one or more exons, presumably during pre-mRNA splicing in the nucleus; this phenomenon is termed nonsense-mediated altered splicing (NAS), and its underlying mechanism is unclear1,2,5,6. By analyzing NAS in BRCA1, we show here that inappropriate exon skipping can be reproduced in vitro, and results from disruption of a splicing enhancer in the coding sequence. Enhancers can be disrupted by single nonsense, missense and translationally silent point mutations, without recognition of an open reading frame as such. These results argue against a nuclear reading-frame scanning mechanism for NAS. Coding-region single-nucleotide polymorphisms7 (cSNPs) within exonic splicing enhancers or silencers may affect the patterns or efficiency of mRNA splicing, which may in turn cause phenotypic variability and variable penetrance of mutations elsewhere in a gene.
引用
收藏
页码:55 / 58
页数:3
相关论文
共 50 条
  • [21] Understanding and predicting the functional consequences of missense mutations in BRCA1 and BRCA2
    Raghad Aljarf
    Mengyuan Shen
    Douglas E. V. Pires
    David B. Ascher
    Scientific Reports, 12
  • [22] Skipping nonsense to maintain function: the paradigm of BRCA2 exon 12
    Meulemans, L.
    Mesman, R.
    Caputo, S. M.
    Krieger, S.
    Guillaud-Bataille, M.
    Caux-Moncoutier, V.
    Leone, M.
    Boutry-Kryza, N.
    Sokolowska, J.
    Tubeuf, H.
    Soukarieh, O.
    Revillion, F.
    Delnatte, C.
    Bonnet-Dorion, F.
    Guibert, V.
    Rousselet, F.
    Bourdon, V.
    Lizard, S.
    Vilquin, P.
    Grout, C.
    Drouet, A.
    Calleja, F. M. G. R.
    Golmard, L.
    Vrieling, H.
    Stoppa-Lyonnet, D.
    Houdayer, C.
    Frebourg, T.
    Vreeswijk, M.
    Martins, A.
    Gaildrat, P.
    EUROPEAN JOURNAL OF HUMAN GENETICS, 2019, 27 : 1132 - 1132
  • [23] Skipping Nonsense to Maintain Function: The Paradigm of BRCA2 Exon 12
    Meulemans, Laetitia
    Mesman, Romy L. S.
    Caputo, Sandrine M.
    Krieger, Sophie
    Guillaud-Bataille, Marine
    Caux-Moncoutier, Virginie
    Leone, Melanie
    Boutry-Kryza, Nadia
    Sokolowska, Johanna
    Revillion, Francoise
    Delnatte, Capucine
    Tubeuf, Helene
    Soukarieh, Omar
    Bonnet-Dorion, Francoise
    Guibert, Virginie
    Bronner, Myriam
    Bourdon, Violaine
    Lizard, Sarab
    Vilquin, Paul
    Privat, Maud
    Drouet, Aurelie
    Grout, Charlotte
    Calleja, Fabienne M. G. R.
    Golmard, Lisa
    Vrieling, Harry
    Stoppa-Lyonnet, Dominique
    Houdayer, Claude
    Frebourg, Thierry
    Vreeswijk, Maaike P. G.
    Martins, Alexandra
    Gaildrat, Pascaline
    CANCER RESEARCH, 2020, 80 (07) : 1374 - 1386
  • [24] In Vitro Analysis of Genomic Instability Triggered by BRCA1 Missense Mutations
    Quaresima, Barbara
    Faniello, Maria Concetta
    Baudi, Francesco
    Crugliano, Telma
    Cuda, Giovanni
    Costanzo, Francesco
    Venuta, Salvatore
    HUMAN MUTATION, 2006, 27 (07) : 715 - U13
  • [25] Missense mutations in the transactivation region of the BRCA1 gene in breast cancer
    Garcia-Patiño, E
    Gomendio, B
    Silva, JM
    Garcia, JM
    España, P
    Bonilla, F
    CANCER GENETICS AND CYTOGENETICS, 1998, 107 (01) : 80 - 81
  • [26] Breast cancer and missense mutations in the transactivation region of the BRCA1 gene
    Garcia, JM
    Dominguez, G
    Silva, JM
    Gonzalez, R
    Navarro, MA
    Corbacho, C
    Martinez, G
    Villanueva, MJ
    Navarro, F
    Bonilla, F
    EUROPEAN JOURNAL OF CANCER, 1998, 34 : S118 - S118
  • [27] A5 A POPULATION SCREENING -DETECTION OF BRCA1 AND OTHER GENES FOUNDER MUTATIONS
    Phillp, B.
    Iwanga, J.
    Mugabi, H.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2018, 28 : 480 - 480
  • [28] BRCA1/2 missense mutations and the value of in-silico analyses
    Sadowski, Carolin E.
    Kohlstedt, Daniela
    Meisel, Cornelia
    Keller, Katja
    Becker, Kerstin
    Mackenroth, Luisa
    Rump, Andreas
    Schroeck, Evelin
    Wimberger, Pauline
    Kast, Karin
    EUROPEAN JOURNAL OF MEDICAL GENETICS, 2017, 60 (11) : 572 - 577
  • [29] Structural characterization of clinically reported missense mutations identified in BRCA1
    Mishra, Neha
    Dubey, Suchita
    Varma, Ashok K.
    ACTA CRYSTALLOGRAPHICA A-FOUNDATION AND ADVANCES, 2021, 77 : C524 - C524
  • [30] BRCA1 Circos: A visualization tool for BRCA1 missense variants
    Jhuraney, Ankita
    Velkova, Aneliya
    Vallee, Maxime P.
    Carvalho, Renato S.
    Tavtigian, Sean V.
    Monteiro, Alvaro N.
    CANCER RESEARCH, 2012, 72